Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.

Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.

BACKGROUND:We evaluated the therapeutic effects of the histone deacetylase inhibitor PXD101 alone and in combination with conventional chemotherapy in treating thyroid cancer. METHODOLOGY/PRINCIPAL FINDINGS:We studied eight cell lines from four types of thyroid cancer (papillary, follicular, anaplas...

Full description

Bibliographic Details
Main Authors: Shu-Fu Lin, Jen-Der Lin, Ting-Chao Chou, Yu-Yao Huang, Richard J Wong
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3796495?pdf=render

Similar Items

Similar Items